NAPLES, Fla., Oct. 6 /PRNewswire/ -- The ability of a proprietary elderberry extract to significantly reduce flu-like symptoms was demonstrated in a double-blind, placebo-controlled study, undertaken on behalf of HerbalScience Group LLC. The pilot, randomized clinical trial was conducted by Dr. Fan-kun Kong, assisted by medical personnel at Shanghai Construction Technical College, China. The study took place during the spring 2009 flu season and involved 64 patients ranging in age from 16 to 60 years.
At the time of enrollment in the study, each of the 64 patients had had three or more flu-like symptoms (fever, headache, muscle aches, coughing, nasal mucus discharge, and nasal congestion) for less than 24 hours. Patients were randomized into two groups and for two days were given four doses daily of the proprietary elderberry extract developed by HerbalScience or a placebo. Patients were asked to self-assess their symptoms at specific intervals over the two days, scoring the severity of symptoms on a Visual Analogue Scale (VAS), with "0" equal to no problem and "10" equal to a pronounced problem.
"By 48 hours, nine patients (28%) in the group receiving the elderberry extract were symptom-free, 19 patients (60%) showed relief from some symptoms and had only one or two mild symptoms (VAS=1), while the remaining four showed symptom improvement but to a lesser degree," said Dr. Kong. "By contrast, complete recovery was not achieved by a single patient in the placebo group, and only 16% showed improvement in one or two symptoms. For most in the placebo group, symptoms remained the same or even worsened over the 48-hour period."
An article by Dr. Kong detailing the clinical study has been published in the peer-reviewed scientific journal Online Journal of Pharmacology and PharmacoKinetics. Dr. Kong holds a Ph.D. in Immunology from the University of Alabama at Birmingham and an M.D. from Hunan Medical University, People's R
|SOURCE HerbalScience Group LLC|
Copyright©2009 PR Newswire.
All rights reserved